Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1

• Benjamin Schumann,
• Katrin Reppe,
• Paulina Kaplonek,
• Annette Wahlbrink,
• Chakkumkal Anish,
• Martin Witzenrath,
• Claney L. Pereira,
• Peter H. Seeberger

Affiliations

Benjamin Schumann

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany

Katrin Reppe

Division of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany

Paulina Kaplonek

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany

Annette Wahlbrink

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany

Chakkumkal Anish

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany

Martin Witzenrath

Division of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany

Claney L. Pereira

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany

Peter H. Seeberger

Max Planck Institute of Colloids and Interfaces, Potsdam, Germany